BioMarin (BMRN) Reports Mixed Q4 Earnings; Guides FY09 Sales
Tweet Send to a Friend
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) reports Q4 EPS of $0.27 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
